Avanos Medical (AVNS) Inventory (2013 - 2026)

Avanos Medical has disclosed Inventory across 14 years of filings, most recently posting $141.3 million for Q1 2026.

• Inventory for Q1 2026 came in at $141.3 million, up 2.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $141.3 million (up 2.32% YoY), and the FY2025 annual result was $148.0 million, up 6.63% from the prior year.
• Inventory came in at $141.3 million for Q1 2026 at Avanos Medical, down from $148.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $200.0 million in Q1 2023 to a low of $132.3 million in Q4 2022.
• The 5-year median for Inventory is $156.6 million (2023), against an average of $157.1 million.
• Peak annual rise in Inventory reached 26.9% in 2023, while the deepest fall reached 19.11% in 2023.
• Avanos Medical's Inventory stood at $132.3 million in 2022, then increased by 23.36% to $163.2 million in 2023, then fell by 14.95% to $138.8 million in 2024, then advanced by 6.63% to $148.0 million in 2025, then declined by 4.53% to $141.3 million in 2026.
• The last three Inventory figures came in at $141.3 million (Q1 2026), $148.0 million (Q4 2025), and $150.6 million (Q3 2025), per Business Quant data.